Publication | Open Access
Comparison of efficacy and toxicity of FOLFIRINOX and gemcitabine with nab-paclitaxel in unresectable pancreatic cancer
109
Citations
8
References
2017
Year
Efficacy and safety of GnP compare favorably to those of FOLFIRINOX in patients with pancreatic cancer. Additional prospective trials are warranted.
| Year | Citations | |
|---|---|---|
Page 1
Page 1